122 related articles for article (PubMed ID: 6936382)
1. Pharmacokinetics of intermediate dose methotrexate in patients of non-Hodgkin's lymphoma and acute lymphocytic leukaemia.
Gadgil SD; Damle SR; Shetty PA; Jussawalla DJ
Indian J Cancer; 1980 Sep; 17(3):176-8. PubMed ID: 6936382
[No Abstract] [Full Text] [Related]
2. [Pharmacokinetics of intravenous methotrexate in children with neoplasms of the hematopoietic system].
Hermann T; Skibińska L; Szwarc E; Michalewska D
Pol Tyg Lek; 1984 May; 39(21):713-6. PubMed ID: 6592554
[No Abstract] [Full Text] [Related]
3. [Results of long-term administration of high-dose methotrexate and its pharmacokinetics in non-Hodgkin's lymphoma in children].
Sasaki K; Fujimoto T; Shingaki Y; Hara T
Rinsho Ketsueki; 1983 Feb; 24(2):96-103. PubMed ID: 6655883
[No Abstract] [Full Text] [Related]
4. [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)].
Sasaki K; Fujimoto T
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):988-96. PubMed ID: 317293
[No Abstract] [Full Text] [Related]
5. Methotrexate with N5-methyl-tetrahydrofolic acid in the treatment of non-Hodgkin's lymphomas and acute leukemias.
Cortellaro M; Boschetti C; Di Padova F; Stramentinoli G; Giulidori P; Pezzoli C; Polli EE
Haematologica; 1983; 68(1):74-86. PubMed ID: 6404711
[No Abstract] [Full Text] [Related]
6. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
7. Current trends in childhood acute lymphocytic leukemia and non-hodgkin's lymphoma.
Castleberry RP
Ala J Med Sci; 1981 Jul; 18(3):243-8. PubMed ID: 6945058
[No Abstract] [Full Text] [Related]
8. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
Sasaki K; Fujimoto T; Goya N
Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma.
Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ
Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429
[TBL] [Abstract][Full Text] [Related]
10. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
Moe PJ; Seip M; Finne PH
Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
[TBL] [Abstract][Full Text] [Related]
11. Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy.
Parker D; Bate CM; Craft AW; Graham-Pole J; Malpas JS; Stansfeld AG
Cancer Chemother Pharmacol; 1980; 4(2):121-7. PubMed ID: 6930333
[TBL] [Abstract][Full Text] [Related]
12. [Testicular recurrences in children with lymphoblastic leukemia and non-Hodgkin's lymphoma].
Sońta-Jakimczyk D; Sroczyńska M; Mazur H; Koehler M; Janik-Moszant A
Pediatr Pol; 1985 Aug; 60(8):597-601. PubMed ID: 3868756
[No Abstract] [Full Text] [Related]
13. [Methotrexate in pediatric hemato-oncology].
Bouffet E; Frappaz D
Pediatrie; 1987; 42(4):241-7. PubMed ID: 3313265
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of oral methotrexate in children.
Balis FM; Savitch JL; Bleyer WA
Cancer Res; 1983 May; 43(5):2342-5. PubMed ID: 6572562
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood].
Borsi J; Révész T; Schuler D
Orv Hetil; 1986 Feb; 127(8):439-42. PubMed ID: 3456552
[No Abstract] [Full Text] [Related]
16. [Thymic origin of juvenile acute lymphocytic leukemia and non-Hodgkin's lymphoma].
Zintl F; Plenert W
Dtsch Gesundheitsw; 1976 Dec; 31(52):2465-72. PubMed ID: 795628
[No Abstract] [Full Text] [Related]
17. [High dose methotrexate in children with acute lymphocytic leukemia].
Moe PJ
Tidsskr Nor Laegeforen; 1979 Feb; 99(5):278-9,284. PubMed ID: 283580
[No Abstract] [Full Text] [Related]
18. Distribution of ABO blood groups in acute leukaemias and lymphomas.
Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.
Borsi JD; Moe PJ
Cancer; 1987 Jul; 60(1):5-13. PubMed ID: 3472638
[TBL] [Abstract][Full Text] [Related]
20. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
